In this episode, guest is Adam Gries, an entrepreneur and software engineer who has sold four companies and developed apps and games that have reached over 80 million users. Alongside Nathan Cheng, he co-founded the Vitalism movement, a revolutionary philosophy and community focused on driving humanity to strive for unlimited lifespans in peak health.

Key Points:

The podcast discusses Vitalism, a movement dedicated to fighting ageing and death to achieve indefinite lifespans in peak health. Adam Gries shares his journey into the longevity movement, highlighting the need for revolutionary resource allocation and public support to combat ageing effectively.

• Vitalism and Longevity: The episode explores the concept of Vitalism, a movement dedicated to fighting ageing and death by promoting a philosophy and community focused on achieving indefinite lifespans in peak health.
• Adam Gries' Journey: Adam Gries, a serial entrepreneur and software engineer, shares his journey into the longevity movement, inspired by his realization during COVID-19 that the fight against ageing and death needed urgent attention.
• The Case Against ageing: Gries argues that ageing is humanity's core problem, causing immense suffering and leading to death. He highlights the need for a revolutionary approach to resource allocation to combat ageing effectively.
• Challenges in Longevity Research: The podcast discusses the significant underfunding of ageing research, noting that despite ageing being the leading cause of death and suffering, it receives minimal investment compared to other healthcare sectors.
• Vitalism's Strategy: The movement's strategy involves unifying and growing a committed group of supporters, amplifying vitalist organizations, and pushing for the creation of "longevity states" where resources and policies are directed towards extending healthy lifespans.
• Public Perception and Action: The episode addresses the paradox of public perception, where many people recognize the importance of health over wealth but remain inactive or skeptical about investing in longevity research and interventions.